sefulness of Tolvaptan preventing for excessive body fluid retension after cardiac surgery
Not Applicable
- Conditions
- valvular heart disease, ischemic heart disease, aortic aneurysm, aortic dissection, cardiac tumor
- Registration Number
- JPRN-UMIN000013153
- Lead Sponsor
- Department of Cardiovascular Surgery, Faculty of Medical Sciences,University of Fukui
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)patients have hypersensitivity to this agent or similar medicine 2)anuria 3)hypernatremia 4)pregnant patients 5)malignant tumor 6)severe hepatopathic patients 7)dialysis patients 8)If the attending physician determines that the patient is an inadequate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method volume of urine , change of body weight, abnormality of the electrolyte
- Secondary Outcome Measures
Name Time Method